These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29850782)

  • 1. Association Between Change in Central Nocturnal Blood Pressure and Urine Albumin-Creatinine Ratio by a Valsartan/Amlodipine Combination: A CPET Study.
    Fujiwara T; Yano Y; Hoshide S; Kanegae H; Hashimoto J; Kario K
    Am J Hypertens; 2018 Aug; 31(9):995-1001. PubMed ID: 29850782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
    Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study.
    Shimizu M; Hoshide S; Ishikawa J; Yano Y; Eguchi K; Kario K
    Am J Hypertens; 2015 Aug; 28(8):980-6. PubMed ID: 25548141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension.
    Fujiwara T; Hoshide S; Yano Y; Kanegae H; Kario K
    J Clin Hypertens (Greenwich); 2017 Dec; 19(12):1319-1326. PubMed ID: 29106031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cilnidipine on normal to marginally elevated urine albumin-creatinine ratio in asymptomatic non-diabetic hypertensive patients: an exponential decay curve analysis.
    Nakatsu T; Toyonaga S; Mashima K; Yuki Y; Nishitani A; Ogawa H; Miyoshi T; Hirohata S; Izumi R; Kusachi S
    Clin Drug Investig; 2010; 30(10):699-706. PubMed ID: 20701401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients.
    Eguchi K; Kario K; Hoshide Y; Hoshide S; Ishikawa J; Morinari M; Ishikawa S; Shimada K
    Am J Hypertens; 2004 Feb; 17(2):112-7. PubMed ID: 14751651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amlodipine, efonidipine, and trichlormethiazide on home blood pressure and upper-normal microalbuminuria assessed by casual spot urine test in essential hypertensive patients.
    Hosaka M; Inoue R; Satoh M; Watabe D; Hanazawa T; Ohkubo T; Asayama K; Obara T; Imai Y;
    Clin Exp Hypertens; 2018; 40(5):468-475. PubMed ID: 29172732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study.
    Boutouyrie P; Achouba A; Trunet P; Laurent S;
    Hypertension; 2010 Jun; 55(6):1314-22. PubMed ID: 20404219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.
    Karalliedde J; Smith A; DeAngelis L; Mirenda V; Kandra A; Botha J; Ferber P; Viberti G
    Hypertension; 2008 Jun; 51(6):1617-23. PubMed ID: 18426991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
    Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T;
    Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet.
    Aritomi S; Koganei H; Wagatsuma H; Mitsui A; Ogawa T; Nitta K; Konda T
    Heart Vessels; 2010 Nov; 25(6):549-55. PubMed ID: 20922532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan.
    Weycker D; Keskinaslan A; Levy DG; Edelsberg J; Kartashov A; Oster G
    Blood Press Suppl; 2008 Dec; 2():5-12. PubMed ID: 19205091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
    Miyagawa K; Dohi Y; Nakazawa A; Sugiura T; Yamashita S; Sato K; Kimura G
    Clin Exp Hypertens; 2010 Jan; 32(1):1-7. PubMed ID: 20144066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing Effects of Aliskiren/Amlodipine Combination and High-Dose Amlodipine Monotherapy on Ambulatory Blood Pressure and Target Organ Protection.
    Mizuno H; Hoshide S; Fukutomi M; Kario K
    J Clin Hypertens (Greenwich); 2016 Jan; 18(1):70-8. PubMed ID: 26176643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.